Market entry and exit by biotech and device companies funded by venture capital.
Start-up companies in the biotechnology and medical device sectors are important sources of health care innovation. This paper describes the role of venture capital in supporting these companies and charts the growth in venture capital financial support. The paper then uses longitudinal data to describe market entry and exit by these companies. Similar factors are associated with entry and exit in the two sectors. Entries and exits in one sector also appear to influence entry in the other. These findings have important implications for developing innovative technologies and ensuring competitive markets in the life sciences.
Burns
Lawton R
LR
Wharton School, University of Pennsylvania, Philadelphia, USA. burnsl@wharton.upenn.edu
Housman
Michael G
MG
Robinson
Charles A
CA
D001709:Biotechnology; D002202:Capital Financing; D003132:Commerce / Q000191:economics*; D004864:Equipment and Supplies; D005381:Financing, Organized / Q000379:methods; D011640:Public Policy; D014481:United States